Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Why Spectrum Pharmaceuticals Rose 19% Today

TheMotleyFool

0 0

Why Spectrum Pharmaceuticals Rose 19% TodayPhoto, wide shot, wide-angle lens, Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png

In response to reporting fourth-quarter earnings, shares of Spectrum Pharmaceuticals (NASDAQ: SPPI), a beaten-down clinical-stage biotech, rose 19% on Friday.

Spectrum doesn't have any revenue yet, so the financial numbers in its "earnings" report aren't really all that meaningful. However, here are a few of the key figures from the quarter:

Image source: Getty Images.

Source Fool.com

Like: 0

SPPI

Teilen